MUSE Silver

2023

Danger Lurks

Entrant Company

Elevate Healthcare

Category

Integrated Marketing - Brand Transformation / Repositioning

Client's Name

Biofrontera

Country / Region

United States

Approximately 8% to 10% of actinic keratosis (AK) will develop into intraepithelial squamous cell carcinoma. When it comes to treating AK, research shows that dermatologists are very consistent and set in their ways because of their satisfaction with current treatments—from cryotherapy to topicals to the most commonly used photodynamic therapy (PDT) brand. Their satisfaction extends beyond clinical expectations and results to include financial aspects and fit with practice and patient flow.

AMELUZ® (aminolevulinic acid hydrochloride) topical gel, 10%, was the first and only PDT approved for field-directed treatment of AK and a clinical profile that delivered high clearance rates, but despite that, had experienced low awareness and slow uptake. This was due primarily to launching into a market that was dominated by entrenched behavior/mindsets and a complacent PDT market leader.

More Silver Winners
Video
2023
MUSE Advertising Awards - Jensen Precast - About Us
Jensen Precast

Entrant Company

Recruit Rooster

Category

Video - Recruitment (NEW)

Country / Region

United States

Publication
2023
MUSE Advertising Awards - LCE 2021 Annual Report

Entrant Company

AARP

Category

Publication - Annual Report

Country / Region

United States

Advertising
2023
MUSE Advertising Awards - Community Lending Ad
Community Lending

Entrant Company

The N2 Company

Category

Advertising - Magazine Ad (Single)

Country / Region

United States

Integrated Marketing
2023
MUSE Advertising Awards - Fed Vip 2022
United Concordia Dental

Entrant Company

LevLane

Category

Integrated Marketing - Integrated Marketing Campaign

Country / Region

United States

This site uses cookies to offer you a better browsing experience. Find out more on how we use cookies and how you can change your settings.
Cookie Policy